SQ HDM SLIT-tablet (ALK) in treatment of asthma - Post hoc results from a randomised trial

Respiratory Medicine

Volumn 108, Issue 10, 2014, Pages 1430-1437

  De Blay, F ^a   Kuna, P ^b   Prieto, L ^c   Ginko, T ^d   Seitzberg, D ^e   Riis, B ^e   Canonica, G W ^f  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Medical University of Lodz ^*  (Poland)

^c UNIVERSITY OF VALENCIA   (Spain)

^d Private Practice   (Germany)

^e ALK ABELLÓ   (Denmark)

^f UNIVERSITY OF GENOA   (Italy)

Author keywords

Asthma; Asthma quality of life; House dust mite; ICS reduction; SLIT tablet

Indexed keywords

CORTICOSTEROID; HOUSE DUST ALLERGEN; PLACEBO; BUDESONIDE; GLUCOCORTICOID; TABLET;

ALLERGIC ASTHMA; ALOPECIA AREATA; ARTICLE; ASTHMA; BACTERIAL INFECTION; DERMATOPHAGOIDES; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EAR PRURITUS; FOLLOW UP; FOOT FRACTURE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; ORAL PRURITUS; PHLEBITIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SUBLINGUAL IMMUNOTHERAPY; ADMINISTRATION AND DOSAGE; ADULT; ANIMAL; CONTROLLED STUDY; IMMUNOLOGY; PROCEDURES; PYROGLYPHIDAE; QUESTIONNAIRE; TABLET; TREATMENT OUTCOME;

ADULT; ANIMALS; ASTHMA; BUDESONIDE; DOUBLE-BLIND METHOD; GLUCOCORTICOIDS; HUMANS; PYROGLYPHIDAE; QUALITY OF LIFE; QUESTIONNAIRES; SUBLINGUAL IMMUNOTHERAPY; TABLETS; TREATMENT OUTCOME;

EID: 84908328880     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.07.017     Document Type: Article

References (32)

1. G.K. Scadding, S.R. Durham, R. Mirakian, N.S. Jones, S.C. Leech, S. Farooque, D. Ryan, S.M. Walker, A.T. Clark, T.A. Dixon, S.R. Jolles, N. Siddique, P. Cullinan, P.H. Howarth, and S.M. Nasser BSACI guidelines for the management of allergic and non-allergic rhinitis Clin Exp Allergy 38 1 2008 19 42
2. M. Marogna, A. Massolo, D. Berra, P. Zanon, E. Chiodini, G.W. Canonica, and G. Passalacqua The type of sensitizing allergen can affect the evolution of respiratory allergy Allergy 61 10 2006 1209 1215
3. J. Bousquet, N. Khaltaev, A.A. Cruz, J. Denburg, W.J. Fokkens, A. Togias, T. Zuberbier, C.E. Baena-Cagnani, G.W. Canonica, W.C. van, I. Agache, N. it-Khaled, C. Bachert, M.S. Blaiss, S. Bonini, L.P. Boulet, P.J. Bousquet, P. Camargos, K.H. Carlsen, Y. Chen, A. Custovic, R. Dahl, P. Demoly, H. Douagui, S.R. Durham, R.G. van Wijk, O. Kalayci, M.A. Kaliner, Y.Y. Kim, M.L. Kowalski, P. Kuna, L.T. Le, C. Lemiere, J. Li, R.F. Lockey, S. Mavale-Manuel, E.O. Meltzer, Y. Mohammad, J. Mullol, R. Naclerio, R.E. O'Hehir, K. Ohta, S. Ouedraogo, S. Palkonen, N. Papadopoulos, G. Passalacqua, R. Pawankar, T.A. Popov, K.F. Rabe, J. Rosado-Pinto, G.K. Scadding, F.E. Simons, E. Toskala, E. Valovirta, C.P. Van, D.Y. Wang, M. Wickman, B.P. Yawn, A. Yorgancioglu, O.M. Yusuf, H. Zar, I. nnesi-Maesano, E.D. Bateman, K.A. Ben, D.A. Boakye, J. Bouchard, P. Burney, W.W. Busse, M. Chan-Yeung, N.H. Chavannes, A. Chuchalin, W.K. Dolen, R. Emuzyte, L. Grouse, M. Humbert, C. Jackson, S.L. Johnston, P.K. Keith, J.P. Kemp, J.M. Klossek, D. Larenas-Linnemann, B. Lipworth, J.L. Malo, G.D. Marshall, C. Naspitz, K. Nekam, B. Niggemann, E. Nizankowska-Mogilnicka, Y. Okamoto, M.P. Orru, P. Potter, D. Price, S.W. Stoloff, O. Vandenplas, G. Viegi, and D. Williams Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) Allergy 63 Suppl. 86 2008 8 160
4. S. Accordini, A.G. Corsico, M. Braggion, M.W. Gerbase, D. Gislason, A. Gulsvik, J. Heinrich, C. Janson, D. Jarvis, R. Jogi, I. Pin, Y. Schoefer, M. Bugiani, L. Cazzoletti, I. Cerveri, and A. Marcon de MR. The cost of persistent asthma in Europe: an international population-based study in adults Int Arch Allergy Immunol 160 1 2013 93 101
5. B.P. Yawn, J.W. Yunginger, P.C. Wollan, C.E. Reed, M.D. Silverstein, and A.G. Harris Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges J Allergy Clin Immunol 103 1 Pt 1 1999 54 59
6. G. Blumberga, L. Groes, L. Haugaard, and R. Dahl Steroid-sparing effect of subcutaneous SQ-standardised specific immunotherapy in moderate and severe house dust mite allergic asthmatics Allergy 61 7 2006 843 848
7. S. Zielen, P. Kardos, and E. Madonini Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: a randomized controlled trial J Allergy Clin Immunol 126 5 2010 942 949
8. L. Jacobsen, B. Niggemann, S. Dreborg, H.A. Ferdousi, S. Halken, A. Host, A. Koivikko, L.A. Norberg, E. Valovirta, U. Wahn, and C. Moller Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study Allergy 62 8 2007 943 948
9. C. Moller, S. Dreborg, H.A. Ferdousi, S. Halken, A. Host, L. Jacobsen, A. Koivikko, D.Y. Koller, B. Niggemann, L.A. Norberg, R. Urbanek, E. Valovirta, and U. Wahn Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study) J Allergy Clin Immunol 109 2 2002 251 256
10. B. Niggemann, L. Jacobsen, S. Dreborg, H.A. Ferdousi, S. Halken, A. Host, A. Koivikko, D.Y. Koller, L.A. Norberg, R. Urbanek, E. Valovirta, U. Wahn, and C. Moller Five-year follow up on the PAT study: specific immunotherapy and long-term prevention of asthma in children Allergy 61 2006 855 859
11. A. Bufe, P. Eberle, E. Franke-Beckmann, J. Funck, M. Kimmig, L. Klimek, R. Knecht, V. Stephan, B. Tholstrup, C. Weisshaar, and F. Kaiser Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy J Allergy Clin Immunol 123 1 2009 167 173
12. S.R. Durham, W. Emminger, A. Kapp, J.G. De Monchy, S. Rak, G.K. Scadding, P.A. Wurtzen, J.S. Andersen, B. Tholstrup, B. Riis, and R. Dahl SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial J Allergy Clin Immunol 129 3 2012 717 725
13. EMA DRAFT note for guidance on the clinical investigation of medicinal products in the treatment of asthma CPMP/EWP/2922/01 Rev.1 2013 London
14. EMEA Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases CHMP/EWP/18504/2006[Final] 2008
15. EMEA Note for guidance on the clinical investigation of medicinal products in the treatment of asthma CPMP/EWP/2922/01 2002 EMEA London
16. GINA Executive Committee Global initiative for asthma; global strategy for asthma management and prevention 2011 National Heart, Lung and Blood Institute, National Institute of Health Bethesda, Maryland, USA. [GINA Guidelines]
17. H. Mosbech, R. Deckelmann, F. de Blay, E.A. Pastorello, E. Trebas-Pietras, L. Prieto Andres, I. Malcus, C. Ljørring, and G.W. Canonica SQ HDM SLIT-tablet (ALK) reduces ICS while keeping asthma control - a randomized, double-blind, placebo-controlled trial J Allergy Clin Immunol 2014 http://dx.doi.org/10.1016/j.jaci.2014.03.019
18. K.F. Rabe, M. Adachi, C.K. Lai, J.B. Soriano, P.A. Vermeire, K.B. Weiss, and S.T. Weiss Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys J Allergy Clin Immunol 114 1 2004 40 47
19. W.C. Moore, E.R. Bleecker, D. Curran-Everett, S.C. Erzurum, B.T. Ameredes, L. Bacharier, W.J. Calhoun, M. Castro, K.F. Chung, M.P. Clark, R.A. Dweik, A.M. Fitzpatrick, B. Gaston, M. Hew, I. Hussain, N.N. Jarjour, E. Israel, B.D. Levy, J.R. Murphy, S.P. Peters, W.G. Teague, D.A. Meyers, W.W. Busse, and S.E. Wenzel Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's severe asthma research program J Allergy Clin Immunol 119 2 2007 405 413
20. National Institutes of Health WHO/GINA workshop report: global strategy for asthma management and prevention NIH publication No 02-3659 2002 1 192
21. E.F. Juniper, P.M. O'Byrne, G.H. Guyatt, P.J. Ferrie, and D.R. King Development and validation of a questionnaire to measure asthma control Eur Respir J 14 4 1999 902 907
22. E.F. Juniper, J. Bousquet, L. Abetz, and E.D. Bateman Identifying 'well-controlled' and 'not well-controlled' asthma using the asthma control questionnaire Respir Med 100 4 2006 616 621
23. E.F. Juniper, A.S. Buist, F.M. Cox, P.J. Ferrie, and D.R. King Validation of a standardized version of the asthma quality of life questionnaire Chest 115 5 1999 1265 1270
24. E.F. Juniper, G.H. Guyatt, R.S. Epstein, P.J. Ferrie, R. Jaeschke, and T.K. Hiller Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials Thorax 47 2 1992 76 83
25. ICH ICH harmonised tripartite guideline topic E2A. Clinical safety data management: definitions and standards for expedited reporting 1994
26. H.K. Reddel, D.R. Taylor, E.D. Bateman, L.P. Boulet, H.A. Boushey, W.W. Busse, T.B. Casale, P. Chanez, P.L. Enright, P.G. Gibson, J.C. de Jongste, H.A. Kerstjens, S.C. Lazarus, M.L. Levy, P.M. O'Byrne, M.R. Partridge, I.D. Pavord, M.R. Sears, P.J. Sterk, S.W. Stoloff, S.D. Sullivan, S.J. Szefler, M.D. Thomas, and S.E. Wenzel An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice Am J Respir Crit Care Med 180 1 2009 59 99
27. S.R. Durham, W. Emminger, A. Kapp, G. Colombo, J.G. De Monchy, S. Rak, G.K. Scadding, J.S. Andersen, B. Riis, and R. Dahl Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet J Allergy Clin Immunol 125 1 2010 131 138
28. M. Nagata, and K. Nakagome Allergen immunotherapy in asthma: current status and future perspectives Allergol Int 59 1 2010 15 19
29. E. Valovirta, A.K. Berstad, B.J. de, A. Bufe, P. Eng, S. Halken, P. Ojeda, G. Roberts, L. Tommerup, E.M. Varga, and I. Winnergard Design and recruitment for the GAP trial, investigating the preventive effect on asthma development of an SQ-standardized grass allergy immunotherapy tablet in children with grass pollen-induced allergic rhinoconjunctivitis Clin Ther 33 10 2011 1537 1546
30. C.G. Lofdahl, T.F. Reiss, J.A. Leff, E. Israel, M.J. Noonan, A.F. Finn, B.C. Seidenberg, T. Capizzi, S. Kundu, and P. Godard Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients BMJ 319 7202 1999 87 90
31. D.J. Evans, D.A. Taylor, O. Zetterstrom, K.F. Chung, B.J. O'Connor, and P.J. Barnes A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma N Engl J Med 337 20 1997 1412 1418
32. GINA Executive Committee Global initiative for asthma; global strategy for asthma management and prevention 2009 National Heart, Lung and Blood Institute, National Institute of Health Bethesda, Maryland, USA 1 112 [GINA Guidelines]